Jci_page_head_homepage_01 Jci_page_head_homepage_02
Dan Yang, Ying Zhang, Hao G. Nguyen, Milka Koupenova, Anil K. Chauhan, Maria Makitalo, Matthew R. Jones, Cynthia St. Hilaire, David C. Seldin, Paul Toselli, Edward Lamperti, Barbara M. Schreiber, Haralambos Gavras, Denisa D. Wagner, Katya Ravid
Published in Volume 116, Issue 7
J Clin Invest. 2006; 116(7):1913–1923 doi:10.1172/JCI27933
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 3
The levels of proinflammatory cytokines are increased in A2B AR-KO mice.

(A) Basal levels of the indicated cytokines were measured in the liver of WT or KO mice. Results are presented as the average of 5 experiments ± SD. (B) LPS-induced cytokine levels in the plasma of WT and KO mice. Mice were injected with LPS (5 μg/g body weight) or vehicle (control [Cont]), and at the indicated hours, plasma cytokine levels were determined. Data are presented as average ± SD for 5 experiments performed in duplicate. TNF-α levels (pg/ml) in WT versus KO mice were 5.64 ± 2.3 versus 11.6 ± 2.8 at baseline; 51 ± 19 versus 106 ± 34 at 3 hours after LPS injection; 21 ± 4 versus 47 ± 5.7 at 16 hours after LPS injection; and 6.2 ± 2.6 versus 18 ± 12 at 24 hours after LPS injection. As to IL-6, the plasma levels (pg/ml) in WT and KO mice were 5.3 ± 3.7 and 5.1 ± 3.8, respectively. (C) For IL-10, the values (pg/ml) at baseline were 6.4 ± 1.1 in WT mice and 7.2 ± 1.5 in KO mice. These relatively low levels are not illustrated clearly in the figure because of scale adjustment.